| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 1,521,649 | 1,503,692 | 1,685,591 | 1,629,137 | | Cost of Revenue | 632,557 | 125,705 | 912,497 | (527,268) | | | Gross Profit | 889,092 | 1,377,987 | 773,094 | 2,156,405 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 314,942 | 815,578 | 92,814 | 1,578,101 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 41,935 | 43,322 | 44,551 | 36,916 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 532,215 | 519,087 | 635,729 | 541,388 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 24,964 | 6,329 | 79,796 | 83,315 | | Earnings Before Interest And Taxes | 557,179 | 525,416 | 715,525 | 624,703 | | Interest Expense | 3,287 | 5,948 | 6,045 | 4,971 | | Income Before Tax | 553,892 | 519,468 | 709,480 | 619,732 | | Income Tax Expense | 150,580 | 153,372 | 191,164 | 182,824 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 403,312 | 366,096 | 518,316 | 436,908 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 403,312 | 366,096 | 518,316 | 436,908 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $403,312 | $366,096 | $518,316 | $436,908 |
|
2.05% Nasdaq 
Income Statement
